| Biomarker ID | 1714 |
| PMID | 26238235 |
| Year | 2015 |
| Biomarker | TEP1 (Telomerase Associated Protein 1) [SNP: rs1760904 GG/AA] |
| Biomarker Basis | Mutation Based |
| Biomolecule | Mutation |
| Source | Blood |
| Subjects | Humans |
| Regulation | NA |
| Odds Ratio/Hazard Ratio/Relative Risk | OR: 0.75 (95% CI: 0.62–0.91) |
| Effect on Pathways | Pathway include: Apoptotic Pathways in Synovial Fibroblasts |
| Experiment | Prostate Cancer Vs No Prostate Cancer |
| Type of Biomarker | Diagnostic |
| Cohort | 1015 PCa cases and 1052 cancer-free controls were selected for this process |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.003 |
| Method Used | RT-PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |